PZ Cormay S.A. Logo

PZ Cormay S.A.

ISIN: PLCMRAY00029 | Ticker: CRM | LEI: 2594006HZJ8OSNK56U87
Sector: Health CareSub-Industry: Health Care Equipment
Country: Poland

About PZ Cormay S.A.

Company Description

Cormay Diagnostics makes affordable to small and mid-size clinical laboratories all over the world the cutting-edge technology and performance demanded by large clinical laboratories.

Combining the 35-years experienced manufacturer of reagents, Cormay with the outstanding technology knowledge of Swiss hematology company, Orphee, we work together every day to build the IVD brand that can be trusted.

Your trust is in the core of everything we do.

Year founded

1985

Served area

Worldwide

Headquarters

Puławska 303, 02-785 Warszawa – Poland

Financial statements

Download as Excel
Line item in (pln) 02.01.2020 01.01.2021 02.01.2021 01.01.2022 01.01.2023
Assets N/A 93,740,000.00 N/A 99,687,000.00 101,975,000.00
Noncurrent Assets N/A 29,823,000.00 N/A 36,247,000.00 43,074,000.00
Property Plant And Equipment N/A 11,038,000.00 N/A 15,583,000.00 17,463,000.00
Goodwill N/A 0.00 N/A 0.00 0.00
Intangible Assets Other Than Goodwill N/A 14,085,000.00 N/A 15,853,000.00 20,555,000.00
Noncurrent Receivables N/A 235,000.00 N/A 49,000.00 52,000.00
Deferred Tax Assets N/A 773,000.00 N/A 1,081,000.00 1,181,000.00
Current Assets N/A 63,917,000.00 N/A 63,440,000.00 58,901,000.00
Inventories N/A 15,168,000.00 N/A 18,587,000.00 26,793,000.00
Trade And Other Current Receivables N/A 12,864,000.00 N/A 14,235,000.00 17,161,000.00
Other Current Financial Assets N/A 26,148,000.00 N/A 28,112,000.00 13,655,000.00
Cash and cash equivalents 7,260,000.00 9,737,000.00 9,737,000.00 2,506,000.00 1,292,000.00
Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners N/A 63,917,000.00 N/A 63,440,000.00 58,901,000.00
Noncurrent Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners N/A 0.00 N/A 0.00 0.00
Equity And Liabilities N/A 93,740,000.00 N/A 99,687,000.00 101,975,000.00
Equity 73,818,000.00 63,316,000.00 62,964,000.00 65,351,000.00 61,756,000.00
Issued Capital N/A 84,205,000.00 N/A 84,205,000.00 84,205,000.00
Retained Earnings N/A -117,910,000.00 N/A -116,626,000.00 -123,195,000.00
Share Premium N/A 92,811,000.00 N/A 92,811,000.00 92,811,000.00
Other Reserves N/A 3,330,000.00 N/A 4,110,000.00 7,439,000.00
Equity Attributable To Owners Of Parent N/A 62,436,000.00 N/A 64,500,000.00 61,260,000.00
Noncontrolling Interests N/A 880,000.00 N/A 851,000.00 496,000.00
Liabilities N/A 30,424,000.00 N/A 34,336,000.00 40,219,000.00
Noncurrent Liabilities N/A 5,118,000.00 N/A 4,412,000.00 4,395,000.00
Noncurrent Provisions For Employee Benefits N/A 199,000.00 N/A 250,000.00 192,000.00
Deferred Tax Liabilities N/A 612,000.00 N/A 550,000.00 705,000.00
Other Noncurrent Financial Liabilities N/A 3,071,000.00 N/A 2,818,000.00 2,862,000.00
Other Noncurrent Nonfinancial Liabilities N/A 1,236,000.00 N/A 794,000.00 636,000.00
Current Liabilities N/A 25,306,000.00 N/A 29,924,000.00 35,824,000.00
Current Provisions For Employee Benefits N/A 673,000.00 N/A 636,000.00 641,000.00
Other Shortterm Provisions N/A 12,547,000.00 N/A 13,772,000.00 13,165,000.00
Trade And Other Current Payables N/A 10,496,000.00 N/A 14,015,000.00 20,648,000.00
Current Tax Liabilities Current N/A 0.00 N/A 0.00 0.00
Other Current Financial Liabilities N/A 1,574,000.00 N/A 1,273,000.00 1,212,000.00
Other Current Nonfinancial Liabilities N/A 16,000.00 N/A 228,000.00 158,000.00
Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale N/A 25,306,000.00 N/A 29,924,000.00 35,824,000.00
Liabilities Included In Disposal Groups Classified As Held For Sale N/A 0.00 N/A 0.00 0.00
Line item in (pln) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue 65,290,000.00 84,732,000.00 85,361,000.00
Other Income 2,769,000.00 1,855,000.00 1,650,000.00
Profit Loss From Operating Activities -7,304,000.00 -68,000.00 -4,314,000.00
Finance Income 1,176,000.00 3,946,000.00 3,156,000.00
Finance Costs 6,694,000.00 1,965,000.00 4,847,000.00
Impairment Loss Impairment Gain And Reversal Of Impairment Loss Determined In Accordance With I F R S9 -121,000.00 156,000.00 237,000.00
Profit Loss Before Tax -12,701,000.00 1,757,000.00 -6,242,000.00
Income Tax Expense Continuing Operations 120,000.00 79,000.00 402,000.00
Profit Loss From Continuing Operations -12,821,000.00 1,678,000.00 -6,644,000.00
Profit Loss From Discontinued Operations 0.00 0.00 0.00
Profit (loss) -12,821,000.00 1,678,000.00 -6,644,000.00
Profit Loss Attributable To Owners Of Parent -12,665,000.00 1,635,000.00 -6,568,000.00
Profit Loss Attributable To Noncontrolling Interests -156,000.00 43,000.00 -76,000.00
Line item in (pln) 01.01.2021 02.01.2020 01.01.2022 02.01.2021 01.01.2023
Profit (loss) -12,821,000.00 N/A 1,678,000.00 N/A -6,644,000.00
Adjustments For Reconcile Profit Loss 12,606,000.00 N/A -2,960,000.00 N/A -2,008,000.00
Adjustments For Income Tax Expense 120,000.00 N/A 79,000.00 N/A 402,000.00
Adjustments For Finance Costs 1,258,000.00 N/A 490,000.00 N/A 1,432,000.00
Adjustments For Decrease Increase In Inventories 1,481,000.00 N/A -7,077,000.00 N/A -9,664,000.00
Adjustments For Decrease Increase In Other Operating Receivables 767,000.00 N/A -145,000.00 N/A N/A
Adjustments For Increase Decrease In Trade Account Payable -4,101,000.00 N/A 2,582,000.00 N/A 5,797,000.00
Adjustments For Increase Decrease In Other Operating Payables 1,932,000.00 N/A -230,000.00 N/A -434,000.00
Adjustments For Depreciation And Amortisation Expense 4,316,000.00 N/A 4,339,000.00 N/A 4,606,000.00
Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss 5,480,000.00 N/A 229,000.00 N/A 200,000.00
Adjustments For Provisions 1,075,000.00 N/A 740,000.00 N/A -972,000.00
Adjustments For Fair Value Gains Losses 1,950,000.00 N/A -2,508,000.00 N/A 1,246,000.00
Other Adjustments For Noncash Items N/A N/A -558,000.00 N/A -167,000.00
Adjustments For Losses Gains On Disposal Of Noncurrent Assets -292,000.00 N/A -290,000.00 N/A N/A
Other Adjustments For Which Cash Effects Are Investing Or Financing Cash Flow N/A N/A -290,000.00 N/A -3,160,000.00
Other Adjustments To Reconcile Profit Loss -590,000.00 N/A -558,000.00 N/A N/A
Adjustments For Reconcile Profit Loss 12,606,000.00 N/A -2,960,000.00 N/A -2,008,000.00
Cash Flows From Used In Operations -215,000.00 N/A -1,282,000.00 N/A -8,652,000.00
Income Taxes Paid Refund Classified As Operating Activities -54,000.00 N/A 187,000.00 N/A 57,000.00
Cash Flows From Used In Operating Activities -161,000.00 N/A -1,469,000.00 N/A -8,709,000.00
Cash Flows From Losing Control Of Subsidiaries Or Other Businesses Classified As Investing Activities 0.00 N/A 0.00 N/A N/A
Other Cash Payments To Acquire Equity Or Debt Instruments Of Other Entities Classified As Investing Activities 7,000,000.00 N/A 0.00 N/A N/A
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities 221,000.00 N/A 61,000.00 N/A 24,000.00
Purchase Of Property Plant And Equipment Classified As Investing Activities 183,000.00 N/A 4,446,000.00 N/A 2,483,000.00
Proceeds From Sales Of Intangible Assets Classified As Investing Activities N/A N/A 0.00 N/A 52,000.00
Purchase Of Intangible Assets Classified As Investing Activities 4,480,000.00 N/A 2,300,000.00 N/A 5,952,000.00
Proceeds From Other Longterm Assets Classified As Investing Activities 11,596,000.00 N/A 2,000,000.00 N/A 17,122,000.00
Proceeds From Government Grants Classified As Investing Activities 743,000.00 N/A 0.00 N/A 206,000.00
Other Inflows Outflows Of Cash Classified As Investing Activities -743,000.00 N/A -39,000.00 N/A 0.00
Cash Flows From Used In Investing Activities 154,000.00 N/A -4,724,000.00 N/A 8,969,000.00
Payments From Changes In Ownership Interests In Subsidiaries 375,000.00 N/A 0.00 N/A N/A
Proceeds From Borrowings Classified As Financing Activities 3,747,000.00 N/A 1,337,000.00 N/A 493,000.00
Repayments Of Borrowings Classified As Financing Activities 0.00 N/A 223,000.00 N/A 535,000.00
Payments Of Lease Liabilities Classified As Financing Activities 938,000.00 N/A 1,273,000.00 N/A 918,000.00
Dividends Paid Classified As Financing Activities 178,000.00 N/A 279,000.00 N/A 5,000.00
Interest Paid Classified As Financing Activities 126,000.00 N/A 181,000.00 N/A 372,000.00
Cash Flows From Used In Financing Activities 2,130,000.00 N/A -619,000.00 N/A -1,337,000.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes 2,123,000.00 N/A -6,812,000.00 N/A -1,077,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents 354,000.00 N/A -419,000.00 N/A -137,000.00
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes 2,477,000.00 N/A -7,231,000.00 N/A -1,214,000.00
Cash and cash equivalents 9,737,000.00 7,260,000.00 2,506,000.00 9,737,000.00 1,292,000.00

Please note that some sums might not add up.

Filings & Publications

2021

Report
Q1
H1
Q3
FY
Consolidated Report
POL
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

PLCMRAY00029

LEI

2594006HZJ8OSNK56U87

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Sub-Industry

Health Care Equipment

Listed Stock Exchange

Warsaw Stock Exchange

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.